Instagram Outage Disrupts Thousands of U.S. Users 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
HAMPTON, N.J., Feb. 13, 2017 -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today upcoming investor events for February and March.
Upcoming Investor Conferences
Anthony Marucci, Co-founder, President and Chief Executive Officer, and Thomas Davis, M.D., Executive Vice President and Chief Medical Officer, will participate in presentations at the following conferences:
- Leerink Partners 6th Annual Global Healthcare Conference on Wednesday, February 15, 2017 at 9:30 a.m. EST in New York – fireside chat
- Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017 at 9:20 a.m. EST in Boston – corporate presentation
Live webcasts of the presentations will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentations will be available for seven days following each event.
2016 Year-End Results and Conference Call/Webcast
- Celldex will release fourth quarter and year-end 2016 financial results on Tuesday, March 14, 2017 after the U.S. financial markets close.
- Celldex will host a conference call/webcast at 4:30 p.m. EDT on the same day to provide an in-depth update on its pipeline and upcoming milestones for 2017.
Event details, including conference call phone numbers, can be accessed on the "Events & Presentations" page under the "Investors & Media" section of the Celldex website.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.
Contact Sarah Cavanaugh Vice President of Investor Relations & Corp Communications Celldex Therapeutics, Inc. (781) 433-3161 [email protected] Charles Liles Associate Director of Investor Relations & Corp Communications Celldex Therapeutics, Inc. (781) 433-3107 [email protected]
